COVID-19: Health Minister calls upon all scientific departments to develop enhanced synergy

Dr. Harsh Vardhan, the minister for Science and Technology, Earth Sciences and Health and Family Welfare reviewed through video-conferencing the various initiatives CSIR has taken up to mitigate COVID-19 in the country.

CSIR has devised five verticals: digital and molecular surveillance; rapid and economical diagnostics; new drugs/repurposing of drugs/vaccines; hospital assistive devices and PPE; supply chain and logistics support systems in order to develop requisite S&T-based solutions to combat COVID-19. Significant developments in each of the five verticals were presented by the vertical coordinating directors.

Dr Vardhan during video conferencing also said, “that all CSIR labs are rising to the occasion and have supported people by supplying sanitisers, masks, ready-to-eat food, apart from developing S&T-based solutions.”

He conveyed to the scientific departments, “To develop enhanced synergy and good-quality coordination for quicker and better results. All scientists and institutions should prioritise the requirements of the time and also contribute in finding quick and deployable solutions.”

“I am happy to see the enthusiasm of CSIR scientists and that CSIR has made good progress since the last review,” Dr. Harsh Vardhan said.

“This is the result of a strong partnership between National Centre for Disease Control (NCDC), New Delhi and CSIR Institute of Genomics and Integrative Biology (CSIR-IGIB), representing the largest submission of sequences, by far, from India by any group. The joint NCDC-CSIR programme will accelerate molecular epidemiology and viral surveillance efforts of India,” Dr. Harsh Vardhan further added.

A drug which has recently been approved by the United States Food and Drug Administration (USFDA) for emergency use in COVID-19 patients is also a major development from the CSIR efforts.

The guidelines were also released by the minsiter for public transport and feeder modes considering social distancing norms developed by CSIR-CRRI (Central Road Research Institute).

Dr Vardhan said, “Post COVID-19, a new normal will develop in the society, setting new standards to live in a better way, in a scientific way which will eventually become good health norms.”

DG CSIR, Dr Shekhar C Mande; Director CSIR-IGIB, Dr Anurag Agarwal; Director CRRI, Dr Satish Chandra; Director CSIR-IIIM, Dr Ram Vishwakarma; Director CSIR-IIP (Indian Institute of Petroleum), Dr Anjan Ray; and Director NAL, Jitendra Yadhav, besides directors of other CSIR labs across the country were present at the video-conference.

  • Related Posts

    Excellence of Accredited Hospitals to be judged on how Friendly they are with Patients

    Patients for Patient Safety Foundation (PFPSF) Partners with CAHO to RollOut an Excellence Program New Delhi: Thanks to some well-meaning organizations, patients are going to be lord of all they…

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    BMJ Research Forum all set to mull over in Delhi on September 5 New Delhi: Research in healthcare in India is a dime a dozen. But the real question that…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

    The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

    Three arrested after liquor bottles found at pharma firm

    Three arrested after liquor bottles found at pharma firm

    NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

    NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

    National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

    National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

    Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

    Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

    Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources

    Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources